Dr David Cutter
Contact information
David Cutter
FRCR, DPhil
Clinical Research Fellow (CTSU) and Consultant Clinical Oncologist (Oxford Cancer Centre)
David Cutter studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre. In 2008 he joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013, he was appointed as a Consultant Clinical Oncologist and continues to work within CTSU upon a programme of work investigating the benefits and risks of cancer treatments.
Recent publications
Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.
Journal article
Challenger A. et al, (2026), Blood Adv
Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.
Journal article
McGale P. et al, (2025), BMJ, 390
Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000.
Journal article
Chamberlin H. et al, (2025), Acta Oncol, 64, 1117 - 1124
Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.
Journal article
Dědečková K. et al, (2025), Radiother Oncol, 208
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.
Journal article
Jones DA. et al, (2025), Br J Haematol, 206, 531 - 540
